Company page

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, trading under the ticker VRTX, is a leading biotechnology company based in the United States. With a market capitalization of approximately $121.16 billion, Vertex focuses on developing innovative therapies for serious diseases, particularly in the field of cystic fibrosis. The company is committed to advancing scientific research and improving patient outcomes through its groundbreaking treatments.